Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ACR classification criteria for systemic lupus erythematosus: complement components.

O Nived1, G Sturfelt

  • 1Department of Rheumatology, University Hospital, Sweden.

Lupus
|December 8, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breast cancer in systemic lupus erythematosus (SLE): receptor status and treatment.

Lupus·2017
Same author

The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients.

Lupus·2017
Same author

Study of Flare Assessment in Systemic Lupus Erythematosus Based on Paper Patients.

Arthritis care & research·2017
Same author

Deciphering systemic lupus erythematosus-associated serum biomarkers reflecting apoptosis and disease activity.

Lupus·2016
Same author

Breast cancer in systemic lupus.

Lupus·2016
Same author

Differences in body structure and function between patients with systemic lupus erythematosus and healthy individuals, with particular reference to joint hypermobility.

Scandinavian journal of rheumatology·2016
Same journal

Association of GPX4 rs713041 and rs4807542 polymorphisms and serum GPX4 levels in Chinese patients with systemic lupus erythematosus.

Lupus·2026
Same journal

Giant cell myocarditis in an 18-year-old patient with new-onset systemic lupus erythematosus: A fatal case of rapidly progressing heart failure.

Lupus·2026
Same journal

An evidence-based specialist nursing protocol for children with hypoprothrombinemia-lupus anticoagulant syndrome (HLAS) and its application research.

Lupus·2026
Same journal

T-bet expression in B cell subsets: Association with T peripheral helper cells and clinical activity in systemic lupus erythematosus.

Lupus·2026
Same journal

Autonomic dysfunction in systemic lupus erythematosus and systemic sclerosis.

Lupus·2026
Same journal

Recent advances in the management of pediatric neuropsychiatric lupus from conventional therapies to novel immunomodulators.

Lupus·2026
See all related articles

Low complement levels, particularly C1q, C4, and C3, are specific diagnostic markers for systemic lupus erythematosus (SLE). These findings suggest their potential inclusion in SLE classification criteria for improved diagnosis.

Area of Science:

  • Immunology
  • Rheumatology

Background:

  • The complement system plays a dual role in systemic lupus erythematosus (SLE) pathogenesis, contributing to disease development while also exhibiting protective functions.
  • Understanding the specific roles of complement components is crucial for diagnosing and managing SLE.

Purpose of the Study:

  • To investigate the diagnostic specificity of low complement levels in patients with SLE.
  • To evaluate the potential of classical complement pathway components as biomarkers for SLE classification.

Main Methods:

  • Analysis of complement component levels (C1q, C4, C3) in patients with SLE.
  • Assessment of the diagnostic specificity of these low complement levels for SLE.

Main Results:

  • Significantly low levels of C1q, C4, and C3 were observed in patients with SLE.

Related Experiment Videos

  • These low complement levels demonstrated high specificity for SLE diagnosis.

    • Conclusions:

    • Low levels of classical complement pathway components (C1q, C4, C3) are highly specific for SLE diagnosis.
    • These components represent promising biomarkers for potential inclusion in future SLE classification criteria.